Airway Therapeutics is a biotechnology company in Sharonville, Ohio that is developing a unique protein replacement therapy to prevent and treat lung disease in the most vulnerable patients, beginning with premature infants with extremely low birth weight. The treatment is based on a decade of research at Cincinnati Children's Hospital Medical Center.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 09/12/14 | $4,600,000 | Series A |
Cincinnati Childrens Innovation Ventures CincyTech Queen City Angels | undisclosed |
